Equillium (EQ) Assets Average (2018 - 2026)
Equillium (EQ) reported Assets Average of $47.5 million for Q1 2026, up 124.34% year-over-year from $21.2 million in Q1 2025, and up 43.04% quarter-over-quarter from $33.2 million in Q4 2025.
Equillium (EQ) Assets Average (2018 - 2026) Analysis & Trends
Equillium (EQ) has 9 years of Assets Average data on file, last reported at $47.5 million in Q1 2026.
- Assets Average for Q1 2026 came in at $47.5 million, up 124.34% year-over-year; the trailing twelve-month figure through Mar 2026 was $47.5 million (up 124.34% YoY), and the FY2025 annual result was $28.7 million, down 24.49% from the prior year.
- Assets Average grew to $47.5 million in Q1 2026 per EQ's latest filing, from $33.2 million in the prior quarter.
- Over five years, Assets Average peaked at $79.8 million in Q1 2022 and troughed at $14.6 million in Q2 2025.
- A 5-year average of $48.0 million and a median of $47.5 million in 2026 frame the typical range for Assets Average.
- The sharpest annual moves came in 2025 and 2026: Assets Average slumped 66.31% in 2025, then surged 124.34% in 2026.
- A 5-year view of Assets Average shows it stood at $63.5 million in 2022, then decreased by 16.76% to $52.9 million in 2023, then sank by 43.21% to $30.0 million in 2024, then increased by 10.54% to $33.2 million in 2025, then soared by 43.04% to $47.5 million in 2026.
- Business Quant data shows EQ's Assets Average at $47.5 million in Q1 2026, $33.2 million in Q4 2025, and $23.5 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 33.42 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 795.91 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 13.04 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 1.72 Bn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 26.03 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 40.89 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 10.06 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 26.06 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 660.38 Mn |
| 10 | Equillium | 293.17 Mn | 232.78 Mn | - | 47.49 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 47.49 Mn |
| Dec 31, 2025 | 33.20 Mn |
| Sep 30, 2025 | 23.45 Mn |
| Jun 30, 2025 | 14.56 Mn |
| Mar 31, 2025 | 21.17 Mn |
| Dec 31, 2024 | 30.03 Mn |
| Sep 30, 2024 | 38.66 Mn |
| Jun 30, 2024 | 43.23 Mn |
| Mar 31, 2024 | 47.06 Mn |
| Dec 31, 2023 | 52.88 Mn |
| Sep 30, 2023 | 56.99 Mn |
| Jun 30, 2023 | 65.28 Mn |
| Mar 31, 2023 | 75.11 Mn |
| Dec 31, 2022 | 63.53 Mn |
| Sep 30, 2022 | 55.55 Mn |
| Jun 30, 2022 | 68.35 Mn |
| Mar 31, 2022 | 79.82 Mn |
| Dec 31, 2021 | 88.94 Mn |
| Sep 30, 2021 | 96.15 Mn |
| Jun 30, 2021 | 103.34 Mn |